Biotechnology news
Biotechnology industry news covers news about business and scientific informationin of the biopharmaceutical market
FDA Unveils Safe Use Initiative That Targets Preventable Harm From Medication Use
The U.S. Food and Drug Administration announced the Safe Use Initiative, a program aimed at reducing the likelihood of preventable harm from medication use. "Too many people suffer unnecessary injuries from avoidable medication misuse, errors and other problems.
Drug Company-sponsored Events For Health Professionals Fail To Disclose Financial Ties
Australian reporting standards for disclosing the ties between pharmaceutical companies and health professionals are not comprehensive enough, according to an analysis in this weeks PLoS Medicine.
FDA Awards Absorption Systems Phase II SBIR Grant For CellPort Technologies™
Absorption Systems LP announced that it has been awarded a Phase II Small Business Innovation Research (SBIR) grant from the U.S. Food and Drug Administration (FDA) to continue development of the company's CellPort Technologies™ testing platform. This unique assay platform enables more specific prediction of potential drug-drug interactions mediated by human drug transport proteins.
GlaxoSmithKline, Pfizer Formally Launch Company To Develop New HIV Treatments
Pharmaceutical companies GlaxoSmithKline (GSK) and Pfizer on Tuesday formally launched ViiV Healthcare, a company focused on the development of new HIV treatments, Dow Jones Newswires/SmartMoney.com reports (11/3).
Study Points To New Uses, Unexpected Side Effects Of Already-existing Drugs
Scientists at the University of North Carolina at Chapel Hill School of Medicine and the University of California, San Francisco have developed and experimentally tested a technique to predict new target diseases for existing drugs.
Aerovance Completes Patient Enrollment In Phase 2b Clinical Trial Of Aerovant(TM) For Treatment Of Uncontrolled Asthma
Aerovance Inc. announced it has completed patient enrollment in a Phase 2b clinical trial of the inhaled dry powder formulation of Aerovant for the treatment of uncontrolled asthma. Top-line results are expected by the second quarter of 2010. Named AeroTrial(TM), the study enrolled approximately 540 patients at 75 sites in the United States and Europe.
Experts Propose 'Global Health Accellerator' To Help New Drugs, Diagnostics, Vaccines Reach Distant Markets
Research firms in developing countries have a medicine cabinet full of affordable and innovative drugs, diagnostics and vaccines on shelves or in development to address "neglected tropical diseases" but need help to get such products to more potential users.
MEPs And Industry Debate Shared Commitment To Deliver 21st Century Healthcare Systems In Times Of Crisis
European policymakers and the pharmaceutical industry need to work collaboratively to ensure the current financial crisis does not stand in the way of delivering healthcare systems fit for the 21st century.
Sanofi Pasteur Presents Safety Data On Menactra(R) Vaccine Given To Infants At Infectious Disease Society Meeting
Sanofi Pasteur, the vaccines division of sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), presented Safety of a Quadrivalent (A,C,Y,W-135) Meningococcal Vaccine When Given to Infants with Other Pediatric Vaccines at the 47th Annual Meeting of the Infectious Diseases Society of America (IDSA) this past weekend.
Ocera Therapeutics Presents Clinical Data Demonstrating AST-120 Relieves Pruritus In Patients With Liver Cirrhosis At The 60th Annual AASLD Meeting
Ocera Therapeutics, Inc. announced that AST-120 (spherical carbon adsorbent) was shown to reduce the severity of pruritus (itching) in patients with chronic liver disease.
